查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球靜脈曲張治療市場——行業規模.份額.趨勢.機會.預測.按類型.按成分.按最終用戶.按地區.競爭對手分析 (2018-2028)
市場調查報告書
商品編碼
1244138

全球靜脈曲張治療市場——行業規模.份額.趨勢.機會.預測.按類型.按成分.按最終用戶.按地區.競爭對手分析 (2018-2028)

Varicose Veins Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, By Component, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球靜脈曲張治療市場預計在 2024-2028 年的預測期內以穩定的複合年增長率增長。

這是由於先進的靜脈曲張治療設備的興起推動了市場增長。 此外，對微創治療的日益偏好預計將推動全球靜脈曲張治療市場的增長。 此外，先進的靜脈曲張治療設備的可用性預計將進一步支持市場增長。 此外，醫療設備的技術進步和現代化以及醫療領域研發活動的增加將為預測期內的靜脈曲張治療市場帶來更多新機遇。 相反，擴大研究和開發以及患者和醫療保健專業人員對靜脈曲張治療的認識不斷提高，有望在未來創造有利可圖的機會。 慢性靜脈功能不全 (CVI) 通常影響下肢，女性患病率為 25-40%，男性為 10-20%。 女性年發病率為 2% 至 6%，男性為 1.9%。

靜脈疾病患病率上升

意識的提高和靜脈曲張患病率的上升隨後推動了市場的增長。 各種政府和非政府組織正在努力提高人們對靜脈疾病的認識，並提高對其治療的先進療法的可用性。 例如在美國，美國血管外科醫師協會和美國靜脈論壇最近發表了關於靜脈曲張診斷的臨床治療建議。 僅在美國，每年約有 3000 萬人患有靜脈曲張，而其中只有 10% 的人接受治療。 肥胖.長時間站立工作和吸煙是靜脈曲張發展的主要危險因素。 此外，據觀察，在懷孕期間，由於妊娠期子宮增大，出現高血壓和下肢靜脈腫脹，以及因荷爾蒙分泌增多而使靜脈壁變弱，診斷為靜脈曲張。靜脈。 靜脈曲張在老年人中很常見，預計老年人口的增加將提振市場。 據估計，41% 的 50 歲以上女性患有靜脈曲張。 據估計，美國 50 歲以上的人口中有 50% 患有靜脈曲張。 與瘦女性相比，中度肥胖女性 (BMI 25-29.9) 患靜脈曲張的風險增加 50%。

技術進步

預計全球市場將受到靜脈曲張治療設備的持續進步和靜脈曲張疾病發病率增加的推動。 通過施加輕微壓力來改善血液循環的加壓裝置的使用在靜脈曲張的治療中越來越受歡迎。 此外，由於激光治療具有30分鐘無痛治療.低復發風險.微創和恢復快等多種優勢，預計將有助於下肢靜脈曲張治療市場的增長。 根據職業安全與健康研究所的數據，全球靜脈曲張的患病率在 10% 到 30% 之間變化。 此外，在預測期內，醫療設備的技術改進和現代化增加了醫療行業的研發力度。 此外，新興地區的增長將很快為靜脈曲張治療市場創造有利可圖的增長機會。

市場細分

參與企業

Alma Lasers Limited.Medtronic Plc..Boston Scientific Corporation (Lumenis Corporation).Sciton, Inc..Merit Medical Systems, Inc..BTG International Limited.Energist Limited.Teleflex Incorporated.AngioDynamics, Inc..El.En SpA集團（Quanta System）是全球靜脈曲張治療市場的主要參與者之一。

報告範圍

本報告將全球靜脈曲張治療市場分為以下幾類，以及下面詳述的行業趨勢：

靜脈曲張治療市場，按類型：

  • 靜脈內消融
  • 硬化療法
  • 手術結紮
  • 剝離

靜脈曲張治療市場，按成分分類：

  • 消融設備
  • 射頻消融設備
  • 激光燒蝕裝置
  • 靜脈閉合產品
  • 其他

最終用戶的靜脈曲張治療市場：

  • 醫院和診所
  • 門診中心
  • 其他

靜脈曲張治療市場，按地區：

  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋

競爭格局

公司概況：對全球靜脈曲張治療市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素.挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章靜脈曲張治療的全球市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型（靜脈消融.硬化療法.手術結紮/去角質）
    • 按組件（消融設備.射頻消融設備.激光消融設備.靜脈閉合產品等）
    • 按最終用戶（醫院/診所.門診診所.其他）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按類型
    • 按組件
    • 最終用戶
    • 按地區

第 6 章北美靜脈曲張治療市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型
    • 按組件
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲靜脈曲張治療市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型
    • 按組件
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太地區靜脈曲張治療市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型
    • 按組件
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章南美靜脈曲張治療市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型
    • 按組件
    • 最終用戶
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲的靜脈曲張治療市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按類型
    • 按組件
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 在南非治療靜脈曲張
    • 沙特下肢靜脈曲張治療藥
    • 阿聯酋下肢靜脈曲張治療

第 11 章市場動態

  • 司機
  • 做

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第13章競爭格局

  • 業務概覽
  • 企業概況
  • 產品服務
  • 財務信息（公開數據）
  • 最新趨勢
  • SWOT 分析
    • Alma Lasers Limited
    • Medtronic Plc.
    • Boston Scientific Corporation（Lumenis Corporation）
    • Sciton, Inc
    • Merit Medical Systems, Inc.
    • BTG International Limited
    • Energist Limited
    • Teleflex Incorporated
    • AngioDynamics, Inc.
    • El. En SpA Group（Quanta System）

第14章 戰略建議

簡介目錄
Product Code: 14580

Global Varicose Veins Treatment Market is anticipated to witness growth of steady CAGR in the forecast period, 2024-2028. It can be ascribed to the rising advanced varicose vein treatment devices escalating the market growth. Besides, surging preference for minimally invasive treatment procedures is expected to drive the growth of global varicose vein treatment market. Additionally, the availability of advanced varicose vein treatment devices is further expected to support market growth. Moreover, the rise in technological advancements and modernization in healthcare devices, and the rise in the research and development activities in the healthcare sector will further create new opportunities for the varicose vein treatment market in the forecasted period. On the contrary, growing R&D and a rise in awareness among healthcare professionals as well as patients regarding varicose vein treatment are expected to create lucrative opportunities in the future. Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25-40% and 10-20% in women and men, respectively. The annual incidence is 2-6% in women and 1.9% in men.

Rising Prevalence of Venous Disorders

Increasing awareness and the rising prevalence of varicose veins are subsequently boosting market growth. Various governmental and non-governmental organizations are taking initiatives to create awareness about venous diseases and the availability of advanced therapies for their treatment. For instance, in the U.S., recently, the Society for Vascular Surgery and the American Venous Forum issued recommendations for the diagnosis of varicose veins for clinical care. In the U.S. alone, about 30 million people are suffering from varicose veins every year, out of which, only 10% of the people seek treatment. Obesity, particularly among women, prolonged standing hours at work, and smoking, are some of the significant risk factors associated with the development of varicose veins. Additionally, varicose veins are observed to be diagnosed during pregnancies due to the enlargement of the gravid uterus, which results in hypertension and distension in the lower-extremity veins and an increase in hormone secretion, leading to the weakening of the venous walls. The varicose vein is most prevalent in the geriatric population, moreover, rising in the geriatric population is anticipated to boost the market. It is estimated that 41% of women over the age of 50 have varicose veins. It is estimated that 50% of the US population over 50 years old has varicose veins. Women who are moderately overweight (BMI 25-29.9) have a 50% increased risk of developing varicose veins compared to women who are not overweight.

Technological Advancements

The global market is likely to be driven by continuous advancements in varicose veins treatment devices and an increase in the incidence of varicose veins illness. The use of a compression device to treat varicose veins has grown in popularity because it improves blood circulation by applying mild pressure. In addition, various advantages of Laser treatment, such as a painless 30-minute procedure, minimal risk of reoccurrence, minimum invasion, quick recovery, etc., are predicted to help the growth of the Varicose Veins Treatment Market over the projection year. According to the Occupational Safety and Health Research Institute, the prevalence of lower limb varicose veins varies between 10% and 30% globally. Furthermore, in the forecasted period, technical improvements and modernization in healthcare devices increased research and development efforts in the healthcare sector. Increased growth in emerging regions will generate lucrative growth opportunities for the Varicose Veins Treatment Market shortly.

Market Segmentation

The Global Varicose Veins Treatment market is segmented based on type, component, end user, and region. Based on type, the market can be segmented into Endovenous Ablation, Sclerotherapy, Surgical Ligation, and Stripping. Based on components, the market can be differentiated into Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, and Others. Based on end users, the market can be differentiated into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa, and South America. In terms of country, among United States, North American region is dominating the overall globe in the varicose vein treatment market. Approximately 23% of US adults have varicose veins. If spider telangiectasias and reticular veins are also considered, the prevalence increases to 80% of men and 85% of women.

Market Players

Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc., Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), is some of the leading players operating in the Global Varicose Veins Treatment Market.

Report Scope:

In this report, Global Varicose Veins Treatment market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Varicose Veins Treatment Market, By Type:

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation
  • Stripping

Varicose Veins Treatment Market, By Component:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Venous Closure Products
  • Others

Varicose Veins Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Varicose Veins Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Varicose Veins Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Varicose Veins Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping)
    • 5.2.2. By Component (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Varicose Veins Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Varicose Veins Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Varicose Veins Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Varicose Veins Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe Varicose Veins Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Varicose Veins Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Varicose Veins Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Varicose Veins Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Varicose Veins Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Varicose Veins Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User

8. Asia-Pacific Varicose Veins Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Varicose Veins Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. India Varicose Veins Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Varicose Veins Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Varicose Veins Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Varicose Veins Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User

9. South America Varicose Veins Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Varicose Veins Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Varicose Veins Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Varicose Veins Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa Varicose Veins Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Varicose Veins Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Varicose Veins Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Varicose Veins Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (As reported)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Alma Lasers Limited
    • 13.6.2. Medtronic Plc.
    • 13.6.3. Boston Scientific Corporation (Lumenis Corporation)
    • 13.6.4. Sciton, Inc
    • 13.6.5. Merit Medical Systems, Inc.
    • 13.6.6. BTG International Limited
    • 13.6.7. Energist Limited
    • 13.6.8. Teleflex Incorporated
    • 13.6.9. AngioDynamics, Inc.
    • 13.6.10. El. En SpA Group (Quanta System)

14. Strategic Recommendations